• Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Protalix BioTherapeutics Inc

+ Add to Watchlist

PLX:IT

873.50 ILs 51.50 5.57%

As of 06:06:05 ET on 08/20/2014.

Snapshot for Protalix BioTherapeutics Inc (PLX)

Open: 926.00 Day's Range: 868.00 - 933.00 Volume: 245,260
Previous Close: 925.00 52wk Range: 868.00 - 1,920.00 1-Yr Rtn: -51.93%

Stock Chart for PLX

No chart data available.
  • PLX:IT 871.70
  • 1D
  • 1M
  • 1Y
925.00
Interactive PLX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PLX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. TA-100 -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.1930
Est. PEG Ratio -
Market Cap (M ILS) 828.12
Shares Outstanding (M) 93.51
30 Day Average Volume 111,724
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PLX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PLX

Protalix BioTherapeutics Inc. is a biotechnology company that has developed plant cell culture technology and a bioreactor system.

David AviezerPresident/CEOTzvi PalashChief Operating Officer
Yoseph ShaaltielExec VP:Research & DevelopmentYossi MaimonVP/CFO/Treasurer/Secretary
More Company Profile & Key Executives for PLX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil